Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis

Reproductive Biology and Endocrinology

Paul Devroey¹  Michel Camus¹  Greta Verheyen¹  Michel De Vos¹  Nikolaos P Polyzos¹  Patrick Haentjens¹  Miriam Baumgarten¹  Dominic Stoop¹ 

[1] Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, B-1090, Brussels, Belgium

关键词: First trimester bleeding;    Pregnancy-induced hypertension;    Pregnancy outcome;    Oocyte donation;   

Others  :  1150636
DOI  :  10.1186/1477-7827-10-42

 received in 2012-01-06, accepted in 2012-05-04,  发布年份 2012

【 摘 要 】

Background

To investigate the obstetrical and perinatal impact of oocyte donation, a cohort of women who conceived after OD was compared with a matched control group of women who became pregnant through in vitro fertilisation with autologous oocytes (AO).

Methods

A matched-pair analysis has been performed at the Centre for Reproductive Medicine of the UZ Brussel, Dutch speaking Free University of Brussel. A total of 410 pregnancies resulted in birth beyond 20 weeks of gestation occurring over a period of 10 years, including 205 oocyte donation pregnancies and 205 ICSI pregnancies with autologous oocytes (AO). Patients in the OD group were matched on a one-to-one basis with the AO group in terms of age, ethnicity, parity and plurality. Matched groups were compared using paired t-tests for continuous variables and McNemar test for categorical variables. A conditional logistic regression analyses was performed adjusting for paternal age, age of the oocyte donor, number of embryos transferred, and singleton/twin pregnancy.

Results

Oocyte donation was associated with an increased risk of pregnancy induced hypertension (PIH) (matched OR: 1.502 CI: 1.024-2.204), and first trimester bleeding (matched OR: 1.493 CI: 1.036-2.15). No differences were observed between the two matched groups with regard to gestational age, mean birth weight and length, head circumference and Apgar scores.

Conclusions

Oocyte donation is associated with an increased risk for PIH and first trimester bleeding independent of the recipients’ age, parity and plurality, and independent of the age of the donor or the partner. However, oocyte donation has no impact on the overall perinatal outcome.

【 授权许可】

   
2012 Stoop et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lutjen P, Trounson A, Leeton J: The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 1984, 307:174-175.
• [2]Rosenwaks Z: Donor eggs: their application in modern reproductive technologies. Fertil Steril 1987, 47:895-909.
• [3]Serhal PF, Craft I: Oocyte donation in 61 patients. Lancet 1989, ii:1185-1187.
• [4]Blanchette H: Obstetric performance of patients after oocyte donation. Am J Obstet Gynecol 1993, 168:1803-1809.
• [5]Pados G, Camus M, Van Steirteghem A, Bonduelle M, Devroey P: The evolution and outcome of pregnancies from oocyte donation. Hum Reprod 1994, 9:538-542.
• [6]Abdalla HI, Billett A, Kan AKS: Obstetric outcome in 232 ovum donation pregnancies. Br J Obstet Gynaecol 1998, 105:332-337.
• [7]Sheffer-Mimouni G, Mashiach S, Dor J, Levran D, Seidman DS: Factors influencing the obstetric and perinatal outcome after oocyte donation. Hum Reprod 2002, 17:2636-2640.
• [8]Edgar AB, Wallace WHB: Pregnancy in women who had cancer in childhood. Eur J of Cancer 2007, 43:1890-1894.
• [9]Borchers AT, Naguwa SM, Keen CL, Gershwin E: The implications of autoimmunity and pregnancy. J Autoimmunity 2010, 34:287-299.
• [10]Ueda Y, Enomoto T, Miyatake T, Fujita M, Yamamoto R, Kanagawa T, Shimizu H, Kimura T: Fertil Steril. 2010, 94:78-84.
• [11]Bonduelle M, Legein J, Derde M-P, Buysse A, Schietecatte J, Wisanto A, Devroey P, Van Steirteghem A, Liebaers I: Comparative follow-up study of 130 children born after intracytoplasmic sperm injection and 130 children born after in-vitro fertilization. Hum Reprod 1995, 10:3327-3331.
• [12]Klatsky PC, Delaney S, Caughey AB, Tran ND, Schattman GL, Rozenwaks Z: The role of embryonic origin in preeclampsia. Obstetrics and Gynecology 2010, 116(6):1387-92.
• [13]Caughey AB, Stotland NE, Washington AE, Escobar GJ: Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol 2005, 106(1):156-161.
• [14]Bodmar LM, Catov JM, Roberts JM: Racial/ethnic differences in the montly variation of preeclampsia incidences. Am J Obstet Gynecol 2007, 196(324):e1-e5.
• [15]Shental O, Friger M, Sheiner E: Ethnic differences in the montly variation of preeclampsia among Bedouin and Jewish parturients in the Negav. Hypertension in pregnancy 2010, 29:342-349.
• [16]Friedman F Jr, Copperman , Broadman ML: Perinatal outcome after embryo transfer in ovum recipients. J Reprod Med 1996, 41:640-644.
• [17]Sönderström-Anttila V, Tiitinen A, Foudila T, Hovatta O: Obstetric and perinatal outcome after oocyte donation: comparison with in-vitro fertilization pregnancies. Hum Reprod 1998, 13:483-490.
• [18]Wiggins DA, Main E: Outcomes of pregnancies achieved by donor egg in vitro fertilisation – a comparison with standard in vitro fertilisation pregnancies. Am J Obstet Gynecol 2005, 192:2002-2008.
• [19]Henne MB, Zhang M, Paroski S, Kelshikar B, Westphal LM: Comparison of obstetric outcomes in recipients of donor oocytes vs; women of advanced maternal age with autologous oocytes. J Reprod Med 2007, 52:585-590.
• [20]Krieg SA, Henne MB, Westphal LM: Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertil Steril 2008, 90:65-70.
• [21]Antinori S, Versaci C, Hossein Gholami G: Oocyte donation in menopausal women. Hum Reprod 1993, 8:1487-1490.
• [22]Antinori S, Versaci C, Panci C: Fetal and maternal morbidity and mortality in menopausal women aged 45–63 years. Hum Reprod 1995, 10:464-469.
• [23]Saftlas AF, Olson DR, Franks AI, Atrash HK, Pokras R: Epidemiology of preeclampsia and eclampsia in the United States, 1979–1986. Am J Obstet Gynecol 1990, 163:460-465.
• [24]Duckitt K, Harrington D: Risk factors for pre-eclampsia at antenatal booking: systemic review of controlled studies. BMJ 2005, 330:1-7.
• [25]Goldman JA, Ashkenazi J, Ben-David M, Feldberg D, Dicker D, Voliovitz I: First trimester bleeding in clinical IVF pregnancies. Hum Reprod 1988, 3:807-809.
• [26]Strobino B, Pantel-Silverman J: Gestational vaginal bleeding and pregnancy outcome. Am J Epidemiol 1989, 129:806-815.
• [27]Weiss JL, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, Hankins GD, Berkowitz RL, Gross SJ, Ddugoff L: Threatened miscarriage: risk factor for poor pregnancy outcome, a population based screening study. Am J Obstet Gynaecol 2004, 190:745-750.
• [28]De Sutter P, Bontinck J, Schutyser V, Van der Elst J, Gerris J, Dhont M: First-trimester bleeding and pregnancy outcome in singletons after assisted reproduction. Hum Reprod 2006, 21:1907-1911.
• [29]Jackson RA, Gibson KA, Wu YW, Croughan MS: Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004, 103:551-563.
• [30]Helmerholst FM, Perquin DA, Donker D, Keirse MJ: Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. Br Med J 2004, 328:261-265.
• [31]McGovern PG, Llorens AJ, Skurnick JH, Weiss G, Goldsmith LT: (2004) Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis. Fertil Steril 2004, 82:1514-1520.
• [32]McDonald DS, Murphy K, Beyene J, Ohlsson A: Perinatal outcome of singleton pregnancies achieved by in vitro fertilization: a systematic review and meta-analysis. J Obstet Gynaecol Can 2005, 27:449-459.
• [33]Romundstad LB, Romundstad PR, Sunde A, von Düring V, Skjaerven R, Gunnell D, Vatten LJ: Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 2008, 30:694-695.
• [34]Wagschal A, Feil R: Genomic imprinting in the placenta. Cytogenet Genome Res 2006, 113:90-98.
• [35]Harlap S, Paltiel O, Deutsch L, Knaanie A, Masalha S, Tiram E, Caplan LS, Malaspina D, Friedlander Y: Paternal age and preeclampsia. Epidemiology 2002, 13:660-667.
• [36]Tan H, Wen SW, Walker M, Demissie K: Missing paternal demographics: a novel indicator for identifying high risk population of adverse pregnancy outcomes. BMC Pregnancy Childbirth 2004, 4(1):21. BioMed Central Full Text
• [37]Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman DE, Slater CC: Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA 2002, 288:2320-2323.
• [38]Jacobsson B, Ladfors L, Milsom I: Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 2004, 104:727-733.
• [39]Sauer MV, Paulson RJ, Lobo RA: Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older. Hum Reprod 1996, 11:2540-2543.
• [40]Tanbo T, Dale P, Lunde O: Obstetric outcome in singleton pregnancies after assisted reproduction. Obstet Gynecol 1995, 86:188-192.